Toxic hepatitis case with prolonged jaundice due to Favipiravir
1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Dicle University School of Medicine, Diyarbakir, Turkiye
Hepatology Forum 2022; 3(3): 95-96 DOI: 10.14744/hf.2022.2022.0007
Favipiravir is an antiviral drug used in the treatment of SARS-CoV2 infection. The main side effects of this drug are teratogenicity and hyperuricemia. Limited information is available on other side effects. Here, we aimed to present our toxic hepatitis case with prolonged jaundice after favipiravir treatment.
Keywords: COVID-19; favipiravir; jaundice; toxic hepatitis.